Your browser doesn't support javascript.
loading
Initial experience in synthesis of (2S,4R)-4-[18 F]fluoroglutamine for clinical application.
Zhang, Yan; Zhang, Lifang; Yang, Jianhua; Wu, Zehui; Ploessl, Karl; Zha, Zhihao; Liu, Fei; Xu, Xiaoxia; Zhu, Hua; Yang, Zhi; Zhu, Lin; Kung, Hank F.
Afiliação
  • Zhang Y; College of Chemistry, Key Laboratory of Radiopharmaceuticals, Ministry of Education, Beijing Normal University, Beijing, China.
  • Zhang L; College of Chemistry, Key Laboratory of Radiopharmaceuticals, Ministry of Education, Beijing Normal University, Beijing, China.
  • Yang J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, China.
  • Wu Z; Beijing Institute of Brain Disorders, Capital Medical University, Beijing, China.
  • Ploessl K; Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Zha Z; Beijing Institute of Brain Disorders, Capital Medical University, Beijing, China.
  • Liu F; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, China.
  • Xu X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, China.
  • Zhu H; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, China.
  • Yang Z; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, China.
  • Zhu L; College of Chemistry, Key Laboratory of Radiopharmaceuticals, Ministry of Education, Beijing Normal University, Beijing, China.
  • Kung HF; Beijing Institute of Brain Disorders, Capital Medical University, Beijing, China.
J Labelled Comp Radiopharm ; 62(5): 209-214, 2019 05 15.
Article em En | MEDLINE | ID: mdl-30861162
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glutamina Limite: Humans Idioma: En Revista: J Labelled Comp Radiopharm Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glutamina Limite: Humans Idioma: En Revista: J Labelled Comp Radiopharm Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China